Literature DB >> 2857209

Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts.

B W Lytle, F D Loop, D M Cosgrove, N B Ratliff, K Easley, P C Taylor.   

Abstract

Serial arteriograms were obtained in 501 patients after coronary bypass grafting. Study I within 5 years of operation (mean interval 15 months) and Study II more than 5 years after (mean interval 88 months, range 60 to 147 months). One hundred patients received both internal mammary artery and saphenous vein grafts: 37, mammary artery grafts only, and 364, vein grafts only. In Study I, 645 (82%) of 786 vein grafts were patent, 42 (5%) stenotic or irregular, and 99 (13%) occluded. Of 140 mammary artery grafts, 136 (97%) were patent, two (2%) stenotic, and two (2%) occluded. Of the 645 vein grafts patent in Study I, 357 (55%) remained patent in Study II, 119 (18%) were stenotic or irregular, and 169 (26%) were occluded. Of 136 mammary artery grafts patent in Study I, 130 (96%) were unchanged, one was stenotic, and five (4%) were occluded in Study II. Early vein graft patency was influenced by the coronary artery grafted and by angina. Progression of vein grafts patent at Study I to stenosis or occlusion at Study II was associated with increasing postoperative interval (p less than 0.00001), interval myocardial infarction (p less than 0.001), angina (p less than 0.001), diabetes (p less than 0.004), hypercholesterolemia (p less than 0.006), and hypertriglyceridemia (p less than 0.02); it was not influenced by the coronary artery grafted. Within 5 years of operation, mammary artery graft patency exceeded vein graft patency. Between 5 and 12 years after operation, the attrition rate of vein grafts greatly exceeded that of mammary artery grafts (p less than 0.0001).

Entities:  

Mesh:

Year:  1985        PMID: 2857209

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  82 in total

Review 1.  Gene therapy for vein graft disease.

Authors:  D G Cable; H V Schaff
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

2.  The string phenomenon: an important cause of internal mammary artery graft failure.

Authors:  R P Villareal; V S Mathur
Journal:  Tex Heart Inst J       Date:  2000

Review 3.  Multivessel coronary bypass grafting with minimal access using cardiopulmonary bypass.

Authors:  M Groh; E A Grossi
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

4.  Present status of the internal mammary artery as a coronary artery bypass conduit at the Texas Heart Institute.

Authors:  G J Reul
Journal:  Tex Heart Inst J       Date:  1985-09

5.  The internal mammary artery bypass graft: praise versus practice.

Authors:  E A Lefrak
Journal:  Tex Heart Inst J       Date:  1987-06

6.  Atherosclerosis: past, present, and future.

Authors:  R J Hall
Journal:  Tex Heart Inst J       Date:  1990

7.  [ECG-gated bypass CT angiography--application in imaging arterial bypasses].

Authors:  B J Wintersperger; G Bastarrika; K Nikolaou; C Rist; A Huber; A Knez; M F Reiser; C R Becker; C Vicol
Journal:  Radiologe       Date:  2004-02       Impact factor: 0.635

8.  Diagnostic accuracy of 64-slice multidetector computed tomography in evaluation of post-coronary artery bypass grafts in correlation with invasive coronary angiography.

Authors:  Rajani Gorantla; J S N Murthy; T R Muralidharan; Rupesh Mandava; Bhawna Dev; Harsha Chandaga; R Rajeswaran; J D Roy Santosham; Santhosh Joseph
Journal:  Indian Heart J       Date:  2012 May-Jun

9.  Pulmonary function tests after different techniques for coronary artery bypass surgery. Saphenous vein versus single versus double internal mammary artery grafts.

Authors:  P G Ferdinande; G Beets; A Michels; E Lesaffre; P Lauwers
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

10.  Determinants of 10-year survival after primary myocardial revascularization.

Authors:  D M Cosgrove; F D Loop; B W Lytle; C C Gill; L A Golding; C Gibson; R W Stewart; P C Taylor; M Goormastic
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.